(Q67293564)

English

Do imipramine and dihydroergosine possess two components--one stimulating 5-HT1 and the other inhibiting 5-HT2 receptors?

scientific article published on 01 January 1990

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2111865

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2111865%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

title

Do imipramine and dihydroergosine possess two components--one stimulating 5-HT1 and the other inhibiting 5-HT2 receptors? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2111865

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2111865%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

author name string

D Pericić

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2111865

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2111865%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

D Mück-Seler

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2111865

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2111865%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

language of work or name

English

0 references

publication date

1 January 1990

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2111865

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2111865%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

Life Sciences

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2111865

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2111865%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

volume

46

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2111865

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2111865%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

issue

19

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2111865

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2111865%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

page(s)

1331-1342

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2111865

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2111865%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

Identifiers

DOI

10.1016/0024-3205(90)90332-L

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2111865

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2111865%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

PubMed publication ID

2111865

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2111865

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2111865%20AND%20SRC:MED&resulttype=core&format=json

(Q67293564)

Do imipramine and dihydroergosine possess two components--one stimulating 5-HT1 and the other inhibiting 5-HT2 receptors?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)